Patents by Inventor Yiwei Tou

Yiwei Tou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-CD47 ANTIBODIES AND USES THEREOF
    Publication number: 20240066121
    Abstract: Provided are anti-CD47 antibodies and fragments thereof. The antibodies and fragments thereof specifically bind to the CD47 protein. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and atherosclerosis are also provided.
    Type: Application
    Filed: August 22, 2023
    Publication date: February 29, 2024
    Inventors: Wenci Gong, Yiwei Tou
  • Anti-CD47 antibodies and uses thereof
    Patent number: 11883495
    Abstract: Provided are anti-CD47 antibodies and fragments thereof. The antibodies and fragments thereof specifically bind to the CD47 protein. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and atherosclerosis are also provided.
    Type: Grant
    Filed: May 10, 2021
    Date of Patent: January 30, 2024
    Assignee: Lepu Biopharma Co., Ltd.
    Inventors: Wenci Gong, Yiwei Tou
  • BIFUNCTIONAL MOLECULES TARGETING PD-L1 AND TGF-BETA
    Publication number: 20230287125
    Abstract: Provided are anti-PD-L1 antibodies with superior activities in blocking the PD-1 and PD-L1 interactions. Also provided are multifunctional molecules that include the anti-PD-L1 antibodies or fragments thereof fused to an extracellular domain of human TGF-beta receptor type-2.
    Type: Application
    Filed: July 27, 2021
    Publication date: September 14, 2023
    Inventors: Wenci GONG, Yiwei TOU
  • ANTI-CD47 ANTIBODIES AND USES THEREOF
    Publication number: 20220127357
    Abstract: Provided are anti-CD47 antibodies and fragments thereof. The antibodies and fragments thereof specifically bind to the CD47 protein. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and atherosclerosis are also provided.
    Type: Application
    Filed: May 10, 2021
    Publication date: April 28, 2022
    Inventors: Wenci Gong, Yiwei Tou
  • Bifunctional molecules targeting PD-L1 and TGF-?
    Patent number: 11028174
    Abstract: Provided are anti-PD-L1 antibodies with superior activities in blocking the PD-1 and PD-L1 interactions. Also provided are multifunctional molecules that include the anti-PD-L1 antibodies or fragments thereof fused to an extracellular domain of human TGF-beta receptor type-2.
    Type: Grant
    Filed: August 28, 2020
    Date of Patent: June 8, 2021
    Assignee: Lepu Biopharma Co., Ltd.
    Inventors: Wenci Gong, Yiwei Tou
  • Anti-TIGIT antibodies and uses thereof
    Patent number: 11028172
    Abstract: Provided are anti-TIGIT antibodies and fragments thereof. The antibodies and fragments thereof specifically bind to the TIGIT protein. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and viral infections are also provided.
    Type: Grant
    Filed: December 10, 2020
    Date of Patent: June 8, 2021
    Assignee: Lepu Biopharma Co., Ltd.
    Inventors: Wenci Gong, Yiwei Tou
  • Anti-CD47 antibodies and uses thereof
    Patent number: 11014984
    Abstract: Provided are anti-CD47 antibodies and fragments thereof. The antibodies and fragments thereof specifically bind to the CD47 protein. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and atherosclerosis are also provided.
    Type: Grant
    Filed: August 21, 2020
    Date of Patent: May 25, 2021
    Assignee: Lepu Biopharma Co., Ltd.
    Inventors: Wenci Gong, Yiwei Tou
  • ANTI-CD47 ANTIBODIES AND USES THEREOF
    Publication number: 20200399367
    Abstract: Provided are anti-CD47 antibodies and fragments thereof. The antibodies and fragments thereof specifically bind to the CD47 protein. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and atherosclerosis are also provided.
    Type: Application
    Filed: August 21, 2020
    Publication date: December 24, 2020
    Inventors: Wenci Gong, Zhaokun Meng, Yiwei Tou